| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/11/2000 | US6013501 Hippuricase gene |
| 01/11/2000 | US6013499 Rho target protein kinase p160 |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013495 Methods of use for integrin B1C cell growth inhibitor |
| 01/11/2000 | US6013489 Using a recombinant nucleic acid sequence encoding a polypeptide for degrading or modifying pectin or pectin containing vegetable or plant material; incubating pectin or plant material with degrading enzyme |
| 01/11/2000 | US6013487 Chimeric RNA molecules generated by trans-splicing |
| 01/11/2000 | US6013485 Producing a mixture of metabolically active heat shock proteins; culturing yeast which contain heat shock proteins, heating the yeast solution, cooling the yeast solution, isolating heat shock proteins from solution |
| 01/11/2000 | US6013484 HIV-3 retrovirus and its use |
| 01/11/2000 | US6013483 Polynucleotide sequence coding an activator protein; for diagnosis of sensitivity and prevention of disease |
| 01/11/2000 | US6013482 Polynucleotide sequence coding a ahdesion protein that is on the surface of a cell; for screening drugs that modulate cell surface protein activity; diagnosis of bacterial infection; bactericides |
| 01/11/2000 | US6013481 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
| 01/11/2000 | US6013480 Antagonists of interleukin-15 |
| 01/11/2000 | US6013479 Human Emr1-like G protein coupled receptor |
| 01/11/2000 | US6013478 Producing modified human polypeptides in cells; culturing cell transformed with a replicable expression vector containing modified nucleotide and amino acid sequences, recovering the expressed product polypeptide |
| 01/11/2000 | US6013477 Polypeptide molecule with cellular growth activity; for detecting mutations in the coding sequence of the polypeptide; wound healing agents; antiproliferative agents |
| 01/11/2000 | US6013476 DNA encoding tumor necrosis related receptor TR7 |
| 01/11/2000 | US6013475 Nucleotide sequences coding a protein that binds to a receptor/ligand complex; for treatment of autoimmune diseases, graft rejection, and cancer |
| 01/11/2000 | US6013474 Calcium channel compositions and methods |
| 01/11/2000 | US6013473 Nucleic acid sequence encoding a deoxyribonucleic acid repair enzyme; for treatment, prevention, and diagnosing cancer; antitumor/anticarcinogenic agents |
| 01/11/2000 | US6013471 DNA encoding hK2 variant polypeptides |
| 01/11/2000 | US6013470 Family of mammalian potassium channels, their cloning and their use especially for the screening of drugs |
| 01/11/2000 | US6013469 Nucleic acid coding a mammalian transport protein gene; for the treatment of diseases associated with chromosomal translocation; anticarcinogenic agent; antiproliferative agent |
| 01/11/2000 | US6013463 Diagnostic test kit for detecting campylobacter infection; for diagnosis of peptic ulcer disease or gastrointestinal cancer |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | US6013453 Libraries of dna sequences encoding zinc finger binding motifs for display on a viral particle, together with methods of designing zinc finger binding polypeptides for binding to a target sequence |
| 01/11/2000 | US6013452 Fungi such as aspergillus oryzae which do not produce proteases, useful as hosts for production of proteins susceptible to proteolytic degradation by proteases usually produced by the fungi |
| 01/11/2000 | US6013450 CAF1-related protein |
| 01/11/2000 | US6013448 Pancreas-derived serpin |
| 01/11/2000 | US6013436 Compositions and methods for diagnosis of mutation in the von Hippel-Lindau tumor suppressor gene |
| 01/11/2000 | US6013433 Baculovirus expression vectors and recombinant antigens for detecting type-specific antibodies to herpes simplex virus |
| 01/11/2000 | US6013432 Testing kit to detect the presence of antibodies to a human immunodeficiency virus in a sample; for diagnosis of human immunodeficiency virus infection or evaluating stage of infection; for vaccine development |
| 01/11/2000 | US6013268 Methods for enhancement of protective immune responses |
| 01/11/2000 | US6013267 Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
| 01/11/2000 | US6013266 Live attenuated bacteria of the species Actinobacillus pleuropneumoniae |
| 01/11/2000 | US6013265 For immunization against and preventing clinical symptoms associated with herpes simplex virus infections |
| 01/11/2000 | US6013263 As inhibitory of human and non-human retroviral, especially human immunodeficiency viurs (hiv), transmission to uninfected cells |
| 01/11/2000 | US6013262 Recombinant papilloma virus L1 |
| 01/11/2000 | US6013261 For immunization |
| 01/11/2000 | US6013258 Immunogenic peptides from the HPV E7 protein |
| 01/11/2000 | US6013257 Neurotactin and uses therefor |
| 01/11/2000 | CA2107118C Isolated osteogenic factor |
| 01/11/2000 | CA2072375C Hirudin analog, method of manufacturing thereof and anti-coagulant composition, and secretion vector, transformed microorganisms containing saidvector and manufacturing method of products which is produced from said microorganism |
| 01/11/2000 | CA2057854C Pdgf .alpha.-receptor |
| 01/11/2000 | CA2035900C Protein having urate oxidase activity, recombinant gene coding for this protein, expression vector, microorganisms and transformed cells |
| 01/11/2000 | CA2032481C Prevention of bt resistance development |
| 01/11/2000 | CA1340872C Microbial expression of interleukin ii |
| 01/10/2000 | CA2277406A1 Production of protein preparations with a reduced aggregate content |
| 01/10/2000 | CA2277374A1 Process for the preparation of a protein solution |
| 01/10/2000 | CA2274984A1 Candida albicans gene (csa1) encoding a mycelial surface antigen, and uses thereof |
| 01/10/2000 | CA2274983A1 Meiosis-related gene and promoter |
| 01/10/2000 | CA2237134A1 Csa1 gene coding for a candida albicans surface antigen, diagnostic and therapeutic uses thereof |
| 01/07/2000 | CA2276791A1 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 01/06/2000 | WO2000000829A2 Method and composition to detect c-type retroviral infection |
| 01/06/2000 | WO2000000825A2 Detection and modulation of cellular immunity to immune privileged antigens |
| 01/06/2000 | WO2000000824A1 Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof |
| 01/06/2000 | WO2000000643A2 Methods and reagents for detecting fungal pathogens in a biological sample |
| 01/06/2000 | WO2000000642A1 Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith |
| 01/06/2000 | WO2000000634A2 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 01/06/2000 | WO2000000633A1 OCT1p, A PROTEIN HAVING HOMOLOGY TO THE ORGANIC AND SUGAR TRANSPORTER FAMILY OF PROTEINS, AND USES THEREOF |
| 01/06/2000 | WO2000000625A1 Methods for production of recombinant polypeptides |
| 01/06/2000 | WO2000000617A2 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 01/06/2000 | WO2000000616A2 Marburg virus vaccines |
| 01/06/2000 | WO2000000615A2 Compounds and methods for the diagnosis and treatment of ehrlichia infection |
| 01/06/2000 | WO2000000614A2 NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI) |
| 01/06/2000 | WO2000000613A1 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
| 01/06/2000 | WO2000000612A1 A novel human thrombopoietin mutein |
| 01/06/2000 | WO2000000611A2 14273 receptor, a g-protein coupled receptor |
| 01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
| 01/06/2000 | WO2000000609A2 Molecules associated with apoptosis |
| 01/06/2000 | WO2000000608A2 Immune system molecules |
| 01/06/2000 | WO2000000607A1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid |
| 01/06/2000 | WO2000000606A1 Npy-y7 receptor gene |
| 01/06/2000 | WO2000000605A1 Tmprss2 is a tumor suppressor |
| 01/06/2000 | WO2000000604A1 Methods and compositions for modulating spermatogenesis |
| 01/06/2000 | WO2000000602A1 Novel gaba-b receptor |
| 01/06/2000 | WO2000000601A2 Production of low-temperature, salt-and drought-tolerant transgenic cereal plants |
| 01/06/2000 | WO2000000599A2 Composition for the induction of apoptosis in target cells |
| 01/06/2000 | WO2000000598A2 Plant dwarfing |
| 01/06/2000 | WO2000000597A2 Non-symbiotic plant hemoglobins to maintain cell energy status |
| 01/06/2000 | WO2000000592A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
| 01/06/2000 | WO2000000590A1 Human thyrotropin receptor compositions and use thereof |
| 01/06/2000 | WO2000000589A1 High-efficiency aav helper functions |
| 01/06/2000 | WO2000000516A1 Novel sugar chain-bonded thrombomodulin-like peptide |
| 01/06/2000 | WO2000000515A2 A CHEMOKINE RECEPTOR OBTAINED FROM A cDNA LIBRARY OF FETAL LIVER-SPLEEN |
| 01/06/2000 | WO2000000514A2 Synthetic spiroketal pyranes as potent anti-cancer agents |
| 01/06/2000 | WO2000000513A1 The human gene krab-np (npaawe05) |
| 01/06/2000 | WO2000000512A2 Antifreeze polypeptides from myoxocephalus scorpius and their nucleic acids |
| 01/06/2000 | WO2000000511A1 Monocyte locomotion inhibitory factor |
| 01/06/2000 | WO2000000510A2 Growth factor modulators |
| 01/06/2000 | WO2000000509A2 Peptides for inhibiting hpv e7 proteins |
| 01/06/2000 | WO2000000507A1 Improved process for preparing schiff base adducts of amines with o-hydroxy aldehydes and compositions of matter based thereon |
| 01/06/2000 | WO2000000506A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/06/2000 | WO2000000503A1 Human az-1 gene, variants thereof and expressed gene products |
| 01/06/2000 | WO2000000483A2 Tubulin binding compounds (cobra) |
| 01/06/2000 | WO2000000224A2 Method for transporting a molecular substance in predetermined areas of eucaryotic cells |
| 01/06/2000 | WO2000000218A1 Mucosal targeting immunisation |
| 01/06/2000 | WO2000000217A1 Mucosal targeting immunisation |
| 01/06/2000 | WO2000000214A2 Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms |
| 01/06/2000 | WO2000000185A1 Cloning and uses of the genetic locus bcl-6 |
| 01/06/2000 | WO2000000161A2 Methods for identification of tef-3 interacting factors |